USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AKONNI BIOSYSTEMS, INC.
Address:
400 Sagner Avenue
Suite 300
FREDERICK, MD 21701-6082
Phone:
N/A
URL:
N/A
EIN:
116166492
DUNS:
154704444
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $3,648,628.00 10
SBIR Phase II $5,413,105.00 4

Award List:

Field Portable Gel Element Arrays for Microbial Community Profiling in Subsurface Sediments and Groundwater

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,908.00
Agency:
DOE
Principal Investigator:
Abstract:
In order to implement effective, safe, and scientifically-based approaches to the remediation of contaminated sites, such as some in the DOE complex, engineers and policy makers require fundamental information on microorganisms in the subsurface. In particular, information is needed to identify: … More

SBIR Phase I: Microfluidic Controlled Microarrays for Infectious Disease Diagnostic Applications

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,979.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovative Research (SBIR) Phase I project aims to integrate microfluidc sample preparation and a gel-drop microarray detection technology clinical diagnostic use. The end user will be able to perform testing for the presence of infectious disease and results within 30 minutes.… More

Microfluidic Controlled Gel-Drop Microarrays for Biothreat Diagnostic Devices

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$1,124,649.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Whether in clinical or epidemiological settings, there is a continued need in identification of B. anthracis and unambiguous discrimination it from close relatives and organisms with similar characteristics. Genomic analysis provides direct information about… More

Field Portable Gel Element Arrays for Microbial Community Profiling in Subsurface Sediments and Groundwater

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$749,970.00
Agency:
DOE
Principal Investigator:
Abstract:
A simple-to-use, microarray-based, environmental diagnostic device is needed to enable technicians and engineers to monitor the structure and dynamics of microbial communities in groundwater and subsurface environments. This project addresses this need by integrating complex molecular-microbiology… More

Diagnostic protein array for respiratory infections

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$590,865.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The objective of this project is to transition Argonne-developed intellectual property into the commercial marketplace, and develop a protein array for clinical surveillance and diagnosis of common respiratory infection s, including influenza A, influenza B,… More

Integrated, on-chip RT-MME-PCR for influenza diagnostics; Phase 1 = sample prepar

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$278,423.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Influenza viruses are highly contagious, segmented negative-sense RNA viruses that belong to the family Orthomyxoviridae, causing approximately 114,000 hospitalizations and 20,000 deaths annually. Several drugs are appr oved by the US Food and Drug Administration… More

Diagnostic Influenza RT-PCR Array

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$2,965,534.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Influenza viruses are highly contagious negative-sense RNA viruses cause approximately 114,000 hospitalizations and 20,000 deaths annually. Several drugs are approved by the US Food and Drug Administration (FDA) for tre ating influenza infections, but successful… More

TB Diagnostics at the Point of Care

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$424,061.00
Agency:
HHS
Principal Investigator:
Christopher G. Cooney
Abstract:
DESCRIPTION (provided by applicant): Of all diseases, Tuberculosis (TB) represents one of, if not, the greatest health disparity between whites and minorities [1]. To be specific, for every TB-infected white person in the United States, there are an estima ted 9 African-Americans, 8 Latinos, 6… More

SBIR Phase I: Reel-to-Reel Assembly of Lab-on-a-Film Diagnostic Tests

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,959.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is designed to investigate the feasibility of manufacturing a lab-on-a-film microarray device on a reel-to-reel assembly line. Reel-to-reel manufacturing has the potential to drastically reduce device cost because hundreds of parts per… More

Diagnostic array for aseptic encephalitis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Darrell P. Chandler – 734-428-0713
Abstract:
DESCRIPTION (provided by applicant): ABSTRACT Aseptic encephalitis and meningitis are potentially fatal diseases defined by acute swelling of the brain or protective membranes covering the brain and spinal cord. These diseases can be caused by viruses,bacteria, fungi and parasites. Viruses are… More

SBIR Phase II: Reel-to-Reel Assembly of Lab-on-a-Film Diagnostic Tests

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$498,780.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project is designed to investigate the feasibility of manufacturing a Lab-on-a-Film? microarray device on a reel-to-reel assembly line. Reel-to-reel manufacturing has the potential to drastically reduce device cost because hundreds of parts per… More

Respiratory Panel Flow-Strip: a Point-of-Care Molecular Diagnostic Test

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Christopher G. Cooney – 301-698-0101
Abstract:
DESCRIPTION (provided by applicant): Acute respiratory infections are the third leading cause of death worldwide, and account for 4.2 million deaths annually; more than 40% are children under five. Conventional techniques are often either too slow (e.g.,conventional cultures require 5 to 10 days)… More

A low-cost instrument for nucleic acid isolation.

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$280,784.00
Agency:
HHS
Principal Investigator:
Christopher G. Cooney – 301-698-0101
Abstract:
DESCRIPTION (provided by applicant): Sample preparation frequently presents a bottleneck for clinical molecular biology workflows. Whereas there are many readout detection modalities, there are only a handful of automated sample preparation workflow strategies. Existing instruments that are built… More

TB Diagnostics at the Point of Care

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,198,821.00
Agency:
HHS
Principal Investigator:
Christopher G. Cooney – 301-698-0101
Abstract:
DESCRIPTION (provided by applicant): Of all diseases, tuberculosis (TB) represents one of, if not, the greatest health disparity between whites and minorities [1]. For every TB-infected white person in the United States, there are an estimated 9 African- Americans, 8 Latinos, 6 Native Americans, 23… More